Gabriela Hobbs/LinkedIn, Andrew Kuykendall/ moffitt.org, Yu-Han Chen/LinkedIn
Jul 4, 2026, 12:24
Gabriela Hobbs: Outcomes of MPN Patients with Concurrent Driver Mutations
Gabriela Hobbs, Leukemia Clinical Director at Massachusetts General Hospital, Associate Professor at Harvard Medical School, shared a post on LinkedIn about a recent article she and her colleagues co-authored, published in Blood Neoplasia, adding:
“Congrats Yu-Han Chen for this publication describing outcomes of MPN pts with concurrent MPL and JAK2/CALR mutations!
Thank you Andrew Kuykendall for the collaboration and ASH HIP program for their support!”
Title: Clinical features and outcomes of MPN with concurrent MPL and JAK2/CALR Mutations
Authors: Yu-Han Chen, Shruti Gajjar, Victor You, Rami Komrokji, Valentina Nardi, Harrison Tsai, Zhuoer Xie, Andrew Kuykendall, Gabriela S Hobbs
Stay updated with Hemostasis Today.
-
Oct 9, 2026, 16:23David Boone: Distinguishing Stroke Prevention from Rhythm Control in Atrial Fibrillation
-
Oct 9, 2026, 15:27Mohamed Hegazi: Geostatistical Modelling Maps Global β-Thalassaemia Carrier Prevalence
-
Oct 9, 2026, 15:15Maha Othman: Uncovering the Consensus on TXA in TBI – Call for Collaboration on a Landmark Umbrella Review
-
Oct 9, 2026, 15:07Daniel D. Han: How Inhalation Product Exposure Impairs Cardiac and Platelet Recovery After MI
-
Oct 9, 2026, 14:58William Toole: How Ultrasound-Guided PRP Therapy Relieves Joint and Tendon Pain
-
Oct 9, 2026, 14:50Shayan Mohammadmoradi: In Corpus Christi for the 20th Midwest Platelet Conference
-
Oct 9, 2026, 14:37Tariq Tramboo: High Platelet Concentrate for Osteoarthritis Knee – Recent Meta-Analyses
-
Oct 9, 2026, 14:26Yousma Khan: Hematology Series – Beyond RBCs, WBCs and Platelets
-
Oct 9, 2026, 14:13Jesus Ardila Novoa: Why the WHO’s Historic Essential Medicines List Decision Is Just the Beginning